Botco.ai’s core product is the GenAI Chat Cloud, a HIPAA-compliant, no-code platform for creating fine-tuned virtual chat agents that prioritize accuracy, privacy, and out-of-the-box integrations with EMRs and CRMs. The company emphasizes industry-specific models for Healthcare, Behavioral Health, Senior Living, contact centers and franchises, claiming over seven million conversations handled to date. Botco.ai reports record revenues in Q2 2023 and says it is tripling revenue in 2023, with more than 30 customer go-lives so far this year. A cited customer, Carlton Senior Living, achieved a quarterly ROI of 2500% using the platform. The team highlights enterprise security and a policy of not sharing recorded data, positioning the product for regulated verticals. Longer-term goals include accelerating development, growing revenues, and shipping additional product features and fine-tuned models via an upcoming Series A. Botco.ai offers a GenAI Chat Cloud—a suite of generative AI products designed to help enterprises transform sales, marketing, and customer relationship initiatives through conversational marketing and AI-driven insights. The platform is used across industries including healthcare, wellness, government, and franchise operations. The company plans to use recent funding to catalyze growth and accelerate development of new features and enhancements for the Botco.ai platform. Botco.ai was co-founded by CEO Rebecca Clyde in 2018 and is based in Costa Rica. The company has received industry recognition, including a TiE50 Award and the SaaS category win at Arizona Commerce Authority’s Venture Madness. The articles describe no revenue or user metrics. Botco.ai is a HIPAA-compliant, AI-powered conversational marketing platform that enables automated, personalized conversations across channels such as web and Facebook Messenger. The product includes authoring, webchat, and machine-learning capabilities alongside an Integrated Analytics Dashboard to view chat campaigns. It provides an API-based interface to transfer leads, transcripts, and data into enterprise sales and marketing products like Salesforce, HubSpot, Adobe Marketing Cloud, and Zoho. The company said it will use the new capital to develop its chatbot analytics to drive greater engagement in digital channels. Botco.ai also plans to expand integration capabilities with other CRM systems to simplify transferring leads and transcriptions to sales reps. In September 2021 Botco.ai raised $3.6M in additional seed funding led by VamosVentures. Botco.ai provides a HIPAA-compliant, AI-powered conversational marketing solution that enables multi-channel chat and automated patient interactions at scale. Its platform combines machine learning that improves through use, a live analytics dashboard, and integrations to EHR/CRM systems to personalize conversations and automate appointments. The product includes webchat, authoring tools, API connectivity to systems like Salesforce, HubSpot, Adobe Marketing Cloud and Zoho, and is positioned to reduce hold times and streamline patient intake. Botco.ai says it will use the new capital for product development, including deeper integrations with electronic health records and marketing automation platforms. Healthcare customers named in the articles include American Family Care, STChealth and La Ventana, which use the chat to manage COVID-19 inquiries and high inquiry volumes. The company highlights its mission to improve access and efficiency in healthcare communication by converting more inquiries into appointments.

Total raised

$11M

Funding rounds

4

Latest round

Seed

Latest activity

Sep 2023